Alpha Teknova Stock Today
| TKNO Stock | USD 7.35 0.34 4.85% |
Performance10 of 100
| Odds Of DistressLess than 25
|
Alpha Teknova is selling at 7.35 as of the 28th of November 2024; that is 4.85 percent increase since the beginning of the trading day. The stock's open price was 7.01. Alpha Teknova has about a 25 % chance of experiencing some form of financial distress in the next two years of operation and had a somewhat ok performance during the last 90 days. Equity ratings for Alpha Teknova are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 25th of June 2021 | Category Healthcare | Classification Health Care |
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. The company was founded in 1996 and is headquartered in Hollister, California. Alpha Teknova operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. The company has 53.3 M outstanding shares of which 273.77 K shares are at this time shorted by private and institutional investors with about 2.03 trading days to cover. More on Alpha Teknova
Moving together with Alpha Stock
| 0.78 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
Moving against Alpha Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Alpha Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO President | Stephen Gunstream | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, Health Care, Biotechnology, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsAlpha Teknova can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Alpha Teknova's financial leverage. It provides some insight into what part of Alpha Teknova's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Alpha Teknova (TKNO) is traded on NASDAQ Exchange in USA. It is located in 2451 Bert Dr., Hollister, CA, United States, 95023 and employs 210 people. Alpha Teknova is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 340.1 M. Alpha Teknova conducts business under Biotechnology sector and is part of Health Care industry. The entity has 53.3 M outstanding shares of which 273.77 K shares are at this time shorted by private and institutional investors with about 2.03 trading days to cover.
Alpha Teknova currently holds about 64.73 M in cash with (18.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.3.
Check Alpha Teknova Probability Of Bankruptcy
Ownership AllocationAlpha Teknova holds a total of 53.3 Million outstanding shares. The majority of Alpha Teknova outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Alpha Teknova to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Alpha Teknova. Please pay attention to any change in the institutional holdings of Alpha Teknova as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Alpha Ownership Details
Alpha Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Fourworld Capital Management Llc | 2024-09-30 | 95 K | |
| Morgan Stanley - Brokerage Accounts | 2024-06-30 | 89.5 K | |
| Renaissance Technologies Corp | 2024-09-30 | 86 K | |
| Susquehanna International Group, Llp | 2024-06-30 | 67.5 K | |
| Citigroup Inc | 2024-09-30 | 45.1 K | |
| Fielder Capital Group Llc | 2024-09-30 | 41.8 K | |
| Blackrock Inc | 2024-06-30 | 37.2 K | |
| Northern Trust Corp | 2024-09-30 | 29.8 K | |
| Jefferies Financial Group Inc | 2024-09-30 | 22.4 K | |
| Millennium Management Llc | 2024-06-30 | 1.8 M | |
| Balyasny Asset Management Llc | 2024-09-30 | 1 M |
Alpha Teknova Historical Income Statement
Alpha Stock Against Markets
Alpha Teknova Corporate Management
| Damon JD | Chief Counsel | Profile | |
| Matthew Lowell | Chief Officer | Profile | |
| Ken Gelhaus | Chief Officer | Profile | |
| Damon Terrill | Chief Counsel | Profile | |
| Jennifer Henry | Senior Marketing | Profile | |
| Lisa McCann | Chief Officer | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Alpha Teknova. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Alpha Stock, please use our How to Invest in Alpha Teknova guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alpha Teknova. If investors know Alpha will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alpha Teknova listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.92) | Revenue Per Share 0.917 | Quarterly Revenue Growth (0.17) | Return On Assets (0.15) | Return On Equity (0.42) |
The market value of Alpha Teknova is measured differently than its book value, which is the value of Alpha that is recorded on the company's balance sheet. Investors also form their own opinion of Alpha Teknova's value that differs from its market value or its book value, called intrinsic value, which is Alpha Teknova's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alpha Teknova's market value can be influenced by many factors that don't directly affect Alpha Teknova's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alpha Teknova's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alpha Teknova is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alpha Teknova's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.